Galenical formulations of a fixed dose combination of Valsartan and Aliskiren

Details for Australian Patent Application No. 2010226620 (hide)

Owner Novartis AG

Inventors Ghosh, Indrajit; Li, Shoufeng; Tong, Wei-Qin; Vippagunta, Sudha; Wen, Hong

Agent Davies Collison Cave

Pub. Number AU-A-2010226620

PCT Pub. Number WO2010/107971

Priority 61/161,891 20.03.09 US

Filing date 18 March 2010

Wipo publication date 23 September 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

22 September 2011 PCT application entered the National Phase

  PCT publication WO2010/107971 Priority application(s): WO2010/107971

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010226635-Uplink transmission power control in multi-carrier communication systems

2010226618-Improved chemical synthesis of diazaindoles by Chichibabin cyclization